MNKD-201, an inhaled formulation of nintedanib for IPF, was shown to be safe and well tolerated in a clinical trial with ...

(RTTNews) - Aileron Therapeutics, Inc. (ALRN), Wednesday announced positive topline data from the cohort 2 of Phase 1b study evaluating LTI-03 in patients with idiopathic pulmonary fibrosis (IPF).

The UAB Division of Pulmonary, Allergy and Critical Care Medicine is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, ...

What is cystic fibrosis liver disease? Liver disease associated with cystic fibrosis (CF) has been increasingly diagnosed during recent years, most likely due to the combined effect of systematic ...

PULMONARY alveolar microlithiasis is a rare ... The diagnosis was thought to be diffuse fibrosis or hemosiderosis, but probably not Boeck's sarcoid. The patient was not seen again for 6 years ...

The Center for Regenerative Medicine (CReM) of Boston University and Boston Medical Center will collaborate with GSK to develop stem cell-based models to better understand pulmonary fibrosis and ...

Symptoms of some of the diseases that mimic lung cancer, such as asthma or acid reflux, are common with many conditions. They can include persistent cough, chest pain, shortness of breath, unexplained ...

Pulmonary arterial hypertension (PAH) is one of five types of pulmonary hypertension. It happens when the blood vessels in your lungs narrow and scar so much that it’s hard for blood to move ...

(Curtis Hicks/CBC) You can't see it, you can't smell it and you can't taste it — and it's the No. 1 cause of lung cancer for non-smokers. Radon is a natural radioactive gas that comes from the ...

IS CYSTIC FIBROSIS STILL AN INDICATION FOR LUNG TRANSPLANTATION? Clemence Martin from Chochin Hospital, Paris, France, delivered a talk on cystic fibrosis and lung transplantation. Martin presented ...

London-based GSK is crossing the pond to form a new lung disease research collaboration with Boston scientists. The Big Pharma is joining forces with researchers from the Center for Regenerative ...